Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Immupharma Share Price
  4. Immupharma Share Regulatory News
  5. Annual Financial Report & Notice of AGM

Pin to quick picksImmupharma Regulatory News (IMM)

Immupharma Information

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.34
Bid: 2.10
Ask: 2.31
Change: -0.035 (-1.56%)
Spread: 0.21 (10.00%)
Open: 2.39
High: 2.39
Low: 2.19
Prev. Close: 2.205
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report & Notice of AGM

4 May 2016 07:01

RNS Number : 1388X
Immupharma PLC
04 May 2016
 

 

 4 MAY 2016

 

 

 

ANNUAL REPORT AND ACCOUNTS

NOTICE OF ANNUAL GENERAL MEETING: 26 MAY 2016

 

 

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2015 has been posted to shareholders.

The Annual Report will be available later today, in electronic form, for download on the Company's website www.immupharma.org.

The Company's Annual General Meeting will be held on Thursday 26 May 2016 at 10:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

-Ends-

 

 

 

For further information please contact:

 

ImmuPharma plc (www.immupharma.org)

+ 44 (0) 20 7152 4080

Tim McCarthy, Chairman

Lisa Baderoon, Head of Investor Relations

Twitter: @immupharma

 

+ 44 (0) 7721 413496

 

 

 

Panmure, Gordon (UK) Limited, NOMAD & Broker

 

+44 (0) 20 7886 2500

Fred Walsh / Duncan Monteith, Corporate Finance

Charles Leigh-Pemberton, Corporate Broking

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSSSLFWDFMSELI
12345678910
Date   Source Headline
14th Sep 202210:04 amRNSWritten Response received from the FDA
7th Sep 20228:25 amRNSExercise of Options
31st Aug 20227:00 amRNSFDA response for Type C Meeting - update
30th Aug 202211:29 amRNSExercise of Options
24th Aug 20228:11 amRNSExercise of Options
17th Aug 20226:12 pmRNSTR-1 Notification of major holdings
16th Aug 20228:03 amRNSTotal Voting Rights
11th Aug 20227:00 amRNSResult of Broker Option / PDMR Dealings
4th Aug 20227:00 amRNSInvestor Presentation - Investor Meet Company
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20224:33 pmRNSSubscription/Placing to raise £1.1m; Broker Option
26th Jul 20224:41 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
11th Jul 20227:00 amRNSInitiation of Research
7th Jul 20227:00 amRNSConfirmed FDA response date for Type C Meeting
28th Jun 20225:44 pmRNSAdmission of new ordinary shares of £0.01
28th Jun 202211:42 amRNSResult of AGM
27th Jun 20227:00 amRNSUpdate on Lupuzor
20th Jun 20223:22 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSNotice of AGM & Annual Report & Accounts
25th May 20227:00 amRNSFinals results for y/e 31 December 2021
4th May 20227:00 amRNSUPDATE on LUPUZOR™ PROGRESS to PHASE 3 with AVION
13th Apr 20227:00 amRNSUPDATE on P140 (LUPUZOR™) clinical progress
7th Feb 20227:00 amRNSLUPUZOR UPDATE
10th Jan 20227:00 amRNSTR-1: Notification of major holdings
5th Jan 20229:53 amRNSTR-1: Notification of major holdings
24th Dec 20218:34 amRNSHolding(s) in Company
20th Dec 20217:00 amRNSSubscriptions and Placing to raise £3.55 million
15th Dec 20214:35 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSCOLLABORATION WITH IMPERIAL COLLEGE LONDON
18th Nov 20217:00 amRNSCorporate Update
8th Nov 20214:41 pmRNSSecond Price Monitoring Extn
8th Nov 20214:36 pmRNSPrice Monitoring Extension
11th Oct 20214:35 pmRNSPrice Monitoring Extension
1st Oct 20217:00 amRNSEuronext Delisting
30th Sep 20217:15 amRNSPROF. SYLVIANE MULLER AWARDED ‘LEGION D’HONNEUR’
29th Sep 20217:30 amRNSInterim Results for the 6months ended 30 June 2021
29th Sep 20217:00 amRNSCorporate Update
22nd Sep 20214:36 pmRNSPrice Monitoring Extension
24th Aug 202111:07 amRNSDirector/PDMR Shareholding
20th Aug 20214:40 pmRNSSecond Price Monitoring Extn
20th Aug 20214:35 pmRNSPrice Monitoring Extension
19th Aug 20214:35 pmRNSPrice Monitoring Extension
17th Aug 20218:50 amRNSNotification of Major Holdings
12th Aug 20217:00 amRNSFDA approves the Lupzuor™ PK study
10th Aug 20214:40 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.